For the quarter ending 2026-03-31, DXCM had $199,300K increase in cash & cash equivalents over the period. $449,000K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 199,500 | 267,300 | 283,800 | 179,800 |
| Depreciation and amortization | 67,100 | 65,200 | 63,600 | 63,000 |
| Share-based compensation | 43,300 | 35,000 | 45,100 | 45,300 |
| Non-cash interest expense | 1,000 | 1,700 | 1,900 | 1,800 |
| Deferred income taxes | 300 | 78,900 | 118,000 | -8,900 |
| Net losses on equity investments | 0 | 0 | 78,100 | - |
| Other non-cash income and expenses | 0 | 3,100 | 6,000 | 400 |
| Accounts receivable, net | -124,600 | 106,200 | -237,800 | 184,600 |
| Inventory | 65,200 | 17,800 | 33,600 | 18,500 |
| Prepaid and other assets | -51,000 | 6,900 | 2,400 | 22,000 |
| Operating lease right-of-use assets and liabilities, net | 1,300 | 2,600 | 1,500 | 3,000 |
| Accounts payable and accrued liabilities | 145,100 | -10,100 | -2,300 | 234,000 |
| Accrued payroll and related expenses | -47,100 | -1,200 | 41,300 | 15,900 |
| Deferred revenue and other liabilities | 7,300 | -6,200 | -7,700 | -300 |
| Net cash provided by operating activities | 525,600 | 294,000 | 659,900 | 303,000 |
| Purchases of marketable securities | 688,600 | 0 | 175,900 | 608,200 |
| Proceeds from sale and maturity of marketable securities | 468,200 | 409,600 | 466,200 | 638,700 |
| Purchases of property and equipment | 76,600 | 101,900 | 80,500 | 94,100 |
| Purchases of non-marketable equity securities | 1,500 | 1,200 | 18,000 | - |
| Other investing activities | 0 | -100 | -1,000 | 0 |
| Net cash provided by (used in) investing activities | -298,500 | 306,600 | 192,800 | -63,600 |
| Net proceeds from issuance of common stock | 12,700 | 0 | 13,900 | 0 |
| Purchases of treasury stock | - | 312,800 | 187,200 | - |
| Proceeds from issuance of convertible notes, net of issuance costs | - | 0 | - | - |
| Purchases of capped call transactions | - | 0 | - | - |
| Payments for conversions of senior convertible notes | - | 0 | - | - |
| Repayments for maturity of senior convertible notes | - | 1,207,500 | - | - |
| Payments for taxes related to net share settlement of equity awards | 35,800 | - | - | - |
| Other financing activities | -1,900 | -1,900 | -1,700 | -1,700 |
| Net cash provided by (used in) financing activities | -25,000 | -1,522,200 | -175,000 | -1,700 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -2,800 | 3,800 | -1,100 | 16,500 |
| Increase in cash, cash equivalents and restricted cash | 199,300 | -917,800 | 676,600 | 254,200 |
| Cash, cash equivalents and restricted cash, beginning of period | 919,100 | 1,836,900 | 1,160,300 | 906,100 |
| Cash, cash equivalents and restricted cash, end of period | 1,118,400 | 919,100 | 1,836,900 | 1,160,300 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)